Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2010, 154(1):13-19 | DOI: 10.5507/bp.2010.005

INFECTIOUS COMPLICATIONS OF ARTERIOVENOUS ePTFE GRAFTS FOR HEMODIALYSIS

Petr Bachledaa, Petr Utikala, Lucie Kalinovaa, Martin Köcherb, Marie Cernab, Milan Kolarc, Josef Zadrazild
a 2nd Department of Surgery, University Hospital Olomouc, Czech Republic
b Department of Radiology, University Hospital Olomouc
c Department of Microbiology, University Hospital Olomouc
d 3rd Department of Internal Medicine, University Hospital Olomouc

Background: Insufficient venous vasculature disallows autologous arteriovenous fistula creation. In this case an arteriovenous conduit of expanded polytetrafluoroethylene (ePTFE) interponed between artery and vein is used for hemodialysis. Although arteriovenous graft infection is an infrequent complication, infected grafts cannot be used for hemodialysis and can cause infection, sepsis and bleeding. Treatment options remain limited but the general approach is to maintain functional angioaccess and to eradicate infection.

Aim: to summarize current knowledge of the prevention and treatment of arteriovenous graft infection.

Methods: literature review Conclusions. ePTFE graft present an unreplaceable material used for angioaccess in patients with an insufficient venous vasculature. A number of risk factors causing graft infection is known. Since hemodialysis patients are a highrisk group, an effective strategies for graft infection prevention and early diagnosis should be determined. Among the most important risk factors belong surgical procedure, recurrent venipuncture and other infection disease. The prostheses should be removed when infected, especially in the presence of sepsis. In case of "localized infection", the prostheses can be removed partially only under the condition of careful patient selection and subsequent follow-up.

Keywords: Arteriovenous graft, Hemodialysis, Infection

Received: October 16, 2009; Accepted: March 1, 2010; Published: March 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Bachleda, P., Utikal, P., Kalinova, L., Köcher, M., Cerna, M., Kolar, M., & Zadrazil, J. (2010). INFECTIOUS COMPLICATIONS OF ARTERIOVENOUS ePTFE GRAFTS FOR HEMODIALYSIS. Biomedical papers, 154(1), 13-19. doi: 10.5507/bp.2010.005
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. National Kidney Foundation: Kidney Disease Outcome Quality Initiative (NKF K/DOQI) clinical practice guidelines for vascular access.Am J Kidney Dis 2001; 37:137181. Go to original source...
    2. Ethier J, Mendelssohn DC, Elder SJ, Hasegawa T, Akizawa T, Akiba T et al. Vascular access use and outcomes: an international perspective from the Dialysis Outcomes nad Practice Patterns Study. Nephrol Dial Transplant 2008; 23:32193226. Go to original source... Go to PubMed...
    3. Bachleda P et al. Cévní náhrady v chirurgii arteriovenózních spojek k hemodialýze. Olomouc: Prodos; 2001. p.1216.
    4. Scher LA, Katzman HE. Alternative grafts materials for hemodialysis access. Seminars in Vascular Surgery 2004; 17:1924. Go to original source... Go to PubMed...
    5. Berardinelli L. Grafts and graft materials as vascular substitutes for haemodialysis access construction. Eur J Vasc Endovasc Surg 2006; 32:203211. Go to original source... Go to PubMed...
    6. Norton L, Eiseman B. Replacement of portal vein during pancreatectomy for carcinoma. Surgery 1975; 77: 280294.
    7. Campbell CD, Brooks DH, Webster MW, Bahnson HT et al. The use of expanded microporous polytetrafluoroethylene for limb salvage: A preliminary report. Surgery 1976; 79: 485496.
    8. Volder JGR, Kirkham RL, Kolff WJ. AV shunts created in new ways. Trans Amer Soc Artif Intern Organs 1973; 19:3842. Go to original source...
    9. Baker LD, Johnson JM, Goldfarb D. Expanded polytetrafluoroethylene (PTFE) subcutaneous arteriovenous conduit: an improved vascular access for chronic hemodialysis. Trans Amer Soc Artif Intern Organs 1976; 22:382387.
    10. Kaufman JL, Garb JL, Berman JA, Rhee SW, Norris MA, Friedmann P. A prospective comparison of two expanded polytetrafluoroethylene grafts for linear forearm hemodialysis access: does the manufacturer matter? J Am Coll Surg 1997; 185:7479. Go to original source... Go to PubMed...
    11. Hurlbert SN, Mattos MA et al. Long-term patency rates, complications and cost-effectiveness of polytetrafluoroethylene (PTFE) grafts for hemodialysis access: a prospective study that compares Impra versus Gore-tex grafts. Cardiovasc Surg 1998; 6:652656. Go to original source... Go to PubMed...
    12. Sorom AJ, Hughes CB, McCarthy JT, Jenson BM, Prieto M, Panneton JM et al. Prospective, randomized evaluation of a cuffed expanded polytetrafluoroethylene graft for hemodialysis vascular access. Surgery 2002; 132:135140. Go to original source... Go to PubMed...
    13. Schild AF, Perez E, Gillaspie E, Seaver C, Livingstone J, Thibonnier A. Arteriovenous fistulae vs arteriovenous grafts: a retrospective review of 1 700 consecutive vascular access cases. J Vasc Access 2008; 9:231235. Go to original source...
    14. Young EW, Dykstra DM, Goodkin DA, Mapes DL, Wolfe RA, Held PJ. Hemodialysis vascular access preferences at outcomes in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Kidney International 2002; 61:22662271. Go to original source... Go to PubMed...
    15. Anel RL, Yevzlin AS, Ivanovich P. Vascular access and patient outcomes in hemodialysis: questions answered in recent literature. Arteficial Organs 2003; 27:237241. Go to original source... Go to PubMed...
    16. Schwab SJ, Harrington JT, Singh A, Rohen J, Shohain SH, Perrone RD et al. Vascular access for hemodialysis. Kidney Int 1999; 55:20782090. Go to original source... Go to PubMed...
    17. Anel RL, Yevzlin AS, Ivanovich P. Vascular access and patient outcomes in hemodialysis: questions answered in recent literature. Arteficial Organs 2003; 27:237241. Go to original source... Go to PubMed...
    18. Sarnak MJ, Jaber BL. Mortality caused by sepsis in patients with end-stage renal disease compared with the general population. Kidney Int 2000; 58:17581764. Go to original source... Go to PubMed...
    19. Butterly DW, Schwab SJ. Dialysis access infection. Curr Opin Nephrol Hypertens 2000; 9:631635. Go to original source... Go to PubMed...
    20. The United States Renal Data System 1999 annual data report. Am J Kid Dis 1999; 34: 168176.
    21. Lafrance JP, Rahme E Lelorier J, Iqbal S. Vascular access related infections: definitions, incidence rates, and risk factors. Am J. Kidney Dis 2008; 52:982983. Go to original source... Go to PubMed...
    22. Taylor G, Gravel D Johnston L, Embil J, Holton D, Paton S. Incidence of bloodstream infection in multicenter inception cohorts of hemodialysis patients. Am J Infect Control 2004; 32:155 160. Go to original source... Go to PubMed...
    23. Hoen B, Paul-Dauphin A Hestin D, Kessler M. EPIBACDIAL: A multicenter prospective study of risk factors for bacteremia in chronic dialysis patients. J Am Soc Nephrol 1998; 9:869876. Go to original source...
    24. US Renal Data System. USRDS 2007 Annual Data Report. The national institute of health, national institute of diabetes and digestive and kidney disease, Bethesda, MD, 2007.
    25. US Renal Data System. USRDS 2006 Annual Data Report. The national institute of health, national institute of diabetes and digestive and kidney disease, Bethesda, MD, 2007.
    26. Stevenson KB, Hannah EL, Lowder CA, Adcox MJ, Davidson RL, Mallea MC et al. Epidemiology of hemodialysis vascular access infections from longitudinal infection surveillance data: predicting the impact of NKF-DOQI clinical practice guidelines for vascular access. Am J Kidney Dis 2002; 39:549555. Go to original source... Go to PubMed...
    27. Roberts TL, Obrador GT, St Peter WL, Pereira BJ, Collins AJ. Relationship among catheter insertions, vascular access infections, and anemia management in hemodialysis patients. Kidney Int 2004; 66:24292436. Go to original source... Go to PubMed...
    28. Hung KY, Tsai TJ, Yen CJ, Yen TS. Infection associated with double lumen catheterization for temporary hemodialysis: experience 168 cases. Nephrol Dial Transplant 1995; 10:247251.
    29. Powe NR, Jaar B, Furth SL, Hermann J, Briggs W. Septicemia in dialysis patients: incidence, risk factors and prognosis. Kidney Int 1999; 55:10811090. Go to original source... Go to PubMed...
    30. Kairaitis LK, Gottlieb T. Outcome and complications of temporary haemodialysis catheters. Nephrol Dial Transplant 1999; 14:1710 1714. Go to original source... Go to PubMed...
    31. Mokrzycki MH, Zhang M, H, Cohen H, Golestaneh L, Laut JM, Rosenberg SO. Tunnelled haemodialysis catheter bacteraemia: risk factors for bacteraemia recurrence, infectious complications and mortality. Nephrol Dial Transplant 2006; 21:10241031. Go to original source...
    32. Zibari GB, Rohr MS, Landreneau MD, Bridges RM, DeVault GA, Petty FH, et al. Complications from permanent hemodialysis vascular access. Surgery 1988; 104: 681686.
    33. Raju S. PTFE grafts for hemodialysis access. Techniques for insertion and management of complications. Ann Surg 1987; 206:666 673. Go to original source... Go to PubMed...
    34. Zibari GB, Gadallah MR, Landreneau M, McMillan R, Bridges RM, Costley K et al. Preoperative vancomycin prophylaxis decreases incidence of postoperative hemodialysis vascular access infections. Am J Kidney Dis 1997; 30:343348. Go to original source... Go to PubMed...
    35. Padberg FT, Lee BC, Curl GR. Hemoaccess site infection. Surg Gynecol Obstet 1992; 174:103108.
    36. Minga TE, Flanagan KH, Allon M. Clinical consequences of infected arteriovenous grafts in hemodilaysis patients. Am J Kidney Dis 2001; 38:975978. Go to original source... Go to PubMed...
    37. Schutte WP, Helmer SD, Salazar L, Smith JL. Surgical treatment of infected prosthesis dialysis arteriovenous grafts: total versus partial graft excision. Am J Surg 2007; 193:385388. Go to original source... Go to PubMed...
    38. Sexton DJ. Vascular access infections in patients undergoing dialysis with special emphasis on the role and treatment of Staphylococcus aureus. Infect Dis Clin North Am 2001; 15:731 742. Go to original source... Go to PubMed...
    39. Foley RN, Guo H, Snyder JJ, Gilbertson DT, Collins AJ. Septicemia in the United States dialysis population, 1991 to 1999. J Am Soc Nephrol 2004; 15:10381045. Go to original source... Go to PubMed...
    40. Taylor SM, Eaves GL, Weatherford DA, McAlhany JC Jr, Russel HE, Langan EM 3rd. Results and complications of arteriovenous access dialysis grafts of the lower extremity: a five year review. Am Surg 1996; 62:188191.
    41. Khadra MH, Dwyer AJ, Thompson JF. Advantages of polytetrafluoroethylene arteriovenous loops in the thigh for hemodialysis access. Am J Surg 1997; 173:280283. Go to original source... Go to PubMed...
    42. Kessler M, Hoen B, Mayeux D, Hestin D, Fontenaille C. Bacteremia in patients on chronic hemodialysis: a multicenter prospective survey. Nephron 1993; 64:95100. Go to original source... Go to PubMed...
    43. Allon M, Depner TA, Radeva M, Bailey J, Beddhu S, Butterly D et al. Impact of dialysis dose and membrane on infection-related hospitalisation and death: Results of the HEMO study. J Am Soc Nephrol 2003; 14:18631870. Go to original source... Go to PubMed...
    44. Jaber BL. Bacterial infections in hemodialysis patients: Pathogenesis and prevention. Kidney Int 2005; 67:25082519. Go to original source... Go to PubMed...
    45. Vanholder R, De Smet R, Glorieux G, Argilés A, Baurmeister U, Brunet P, Clark W, Cohen G et al. Review on uremic toxins: Classification, concentration, and interindividual variability. Kidney Int 2003; 63:19341943. Go to original source... Go to PubMed...
    46. Girndt M, Sester U, Sester M, Kaul H, Köhler H. Impaired cellular immune function in patients with end-stage renal failure. Nephrol Dial Transplant 1999; 14:28072810. Go to original source... Go to PubMed...
    47. Dhingra RK, Young EW, Hulbert-Shearon TE, Leavey SF, Port FK. Type of vascular access and mortality in US hemodialysis patients. Kidney Int 2001; 60:14431451. Go to original source... Go to PubMed...
    48. Miller PE, Carlton D, Dierehoi MH, Redden DT, Allon M. Natural history of arteriovenous grafts in hemodialysis patients. Am J Kidney Dis 2000; 36:6874. Go to original source... Go to PubMed...
    49. Kaplowitz LG, Comstock JA, Landwehr DM, Dalton HP, Mayhall CG. A prospective study of infections in hemodialysis patients: Patients hygiene and other risk factors for infection. Infect Control Hosp Epidemiol 1988; 9:534541. Go to original source... Go to PubMed...
    50. Nassar GM, Ayus JC. Infectious complications of the hemodialysis access. Kidney Int 2001; 60:113. Go to original source... Go to PubMed...
    51. Curi MA, Pappas PJ, Silva MB Jr, Patel S, Padberg FT Jr, Jamil Z et al. Hemodialysis access: Influence of the human immunodeficiency virus on patency and infection rates. J Vasc Surg 1999; 29:608616. Go to original source... Go to PubMed...
    52. Bonomo RA, Rice D, Whallen C, Linn D, Eckstein E. Risk factors associated with permanent access-site infections in chronic hemodialysis patients. Infect Control Hosp Epidemiol 1997; 18:757761. Go to original source... Go to PubMed...
    53. Ryan SV, Calligaro KD, McAffee-Bennett S, Doerr KJ, Chang J, Dougherty MJ. Management of infected prosthetic dialysis arteriovenous grafts. J Vasc Surg 2004; 39:7378. Go to original source... Go to PubMed...
    54. Lentino JR, Baddour LM, Wray M, Wong ES, Yu VL. Staphylococcus aureus and other bacteremias in hemodialysis patients: antibiotic therapy and surgical removal of access site. Infection 2000; 28:355360. Go to original source... Go to PubMed...
    55. Wang SA, Levine RB, Carson LA, Arduino MJ, Killar T, Grillo FG, Pearson ML et al. An outbreak of gram-negative bacteremia in hemodialysis patients intraced to hemodialysis machine waste drain ports. Infect Control Hosp Epidemiol 1999; 20:746751. Go to original source... Go to PubMed...
    56. Engemann JJ, Friedman JY, Reed SD, Griffiths RI, Szczech LA, Kaye KS et al. Clinical outcomes and costs due to Staphylococcus aureus bacteremia among patients receiving long-term hemodialysis. Infect Control Hosp Epidemiol 2005; 26:534539. Go to original source... Go to PubMed...
    57. Troidle L, Eisen T, Pacelli L, Finkelstein F. Complications associated with the development of bacteremia with Staphylococcus aureus. Hemodial Int 2007; 11:7275. Go to original source... Go to PubMed...
    58. Klevens RM, Morrison MA, Nadle J, Petit S, Gershman K, Ray S et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 2007; 298:763771. Go to original source... Go to PubMed...
    59. Shorr AF. Epidemiology of staphylococcal resistence. Clin Infect Dis 2007; 45:171176. Go to original source... Go to PubMed...
    60. Shurland S, Zhan M, Bradham DD, Roghmann MC. Comparison of mortality risk associated with bacteremia due to methicillinresistent and methicillin-susceptible Staphylococcus aureus. Infect Control Hosp Epidemiol 2007; 28:273279. Go to original source... Go to PubMed...
    61. Sharpe JN, Shively EH, Polk HC. Clinical and economic outcomes of oral linezolid versus intravenous vancomycin in the treatment of MRSA-complicated lower extremity a soft-tissue infections caused by methicillin-resistent Staphylococcus aureus. Am J Surg 2005; 189:425428. Go to original source... Go to PubMed...
    62. Berns JS. Infection with antimicrobial-resistent microorganisms in dialysis patients. Semin Dial 2003; 16:3037. Go to original source... Go to PubMed...
    63. Hadley AC, Karchmer TB, Russell GB, McBride DG, Freedman BI. The prevalence of resistant bacterial colonization in chronic hemodialysis patients. Am J Nephrol 2007; 27:352359. Go to original source... Go to PubMed...
    64. Barbosa D, Lima L, Silbert S, Sader H, Cendoroglo M, Draibe S et al. Evaluation of the prevalence and risk factors for colonization by vankomycin-resistent Enterococcus among patients on dialysis. Am J Kidney Dis 2004; 44:337343. Go to original source... Go to PubMed...
    65. National Kidney Foundation: KDOQI Clinical Practice Guidelines for Vascular Access. Am J Kidney Dis 2006; 48: 176247. Go to original source...
    66. Davidson IJA. PTFE bridge grafts. In: Davidson IJA, ed. On call vascular access. Austin: RG Landes. Company; 1996.
    67. Almonacid PJ, Pallares EC, Rodriquez AQ, Valdes JS, Rueda Orgaz JA. Comparative study of use of Diastat versus standard wall PTFE grafts in upper arm hemodialysis access. Ann Vasc Surg 2000; 14:659662. Go to original source... Go to PubMed...
    68. Tokars J, Finelli L, Alter MJ, Arduino MJ. National surveillance odf dialysis- associated diseases in the United States, 2001. Semin Dial 2004; 17:310319. Go to original source... Go to PubMed...
    69. Atta A, Eustace J, Song X, Perl TM, Scheel PJ Jr. Outpatient vancomycin use and vancomycin-resistent enterococcal colonization in maintenance dialysis patients. Kidney Int 2001; 59:718724. Go to original source... Go to PubMed...
    70. Falagas ME, Fragoulis KN, Bliziotis IA. Oral rifampicin for prevention of S. aureus carriage related infections in patients with renal failure metaanalysis or randomized controlled trials. Nephrol Dial Transplant 2006; 21: 25362542. Go to original source... Go to PubMed...
    71. Yu VL, Goetz A, Wagener M, Smith PB, Rihs JD, Hanchett J et al. Staphylococcus aureus nasal carriage and infection in patients on hemodialys. Efficacy of antibiotic prophylaxis. N Engl J Med 1986; 315:9196. Go to original source... Go to PubMed...
    72. Kaupp HA, Matulewicz TJ, Lattimer GL, Kremen JE, Celani VJ. Graft infection or graft reaction? Arch Surg 1979; 114:14191426. Go to original source... Go to PubMed...
    73. Bolton W, Cannon JA. Seroma formation associated with PTFE vascular grafts used as arteriovenous fistulae. Dialysis and transplantation 1981; 10:6165.
    74. Ahn SS, Machleder HI, Gupta R, Moore WS. Perigraft seroma: clinical, histologic, and serologic correlates. Am J Surg 1987; 154:173178. Go to original source... Go to PubMed...
    75. Bachleda P et al. Cévní náhrady v chirurgii arteriovenózních spojek k hemodialýze. Olomouc: Prodos; 2001. p.5658.
    76. Bachleda P et al. Cévní náhrady v chirurgii arteriovenózních spojek k hemodialýze. Olomouc: Prodos; 2001. p.7881.
    77. Schild AF, Simon S, Prieto J, Raines J. Single-center review of infections associated with 1574 consecutive access procedures. Vasc Endovasc Surg 2003; 37:2731. Go to original source... Go to PubMed...
    78. Palestro CJ, Vega A, Kim CK, Vallabhajosula S, Goldsmith SJ. Indium 111 labeled leukocyte scintigraphy in hemodialysis accesssite infection. J Nucl Med 1990; 31:319324.
    79. Musso GC, Reynaldi J, Navarro M, Vallone M, Enz P, Vazquez P et al. Hidden clotted vascular access infection diagnosed by fluorodeoxyglucose positron emission tomography. Nephrology 2008; 13:26482655. Go to original source...
    80. Lawrence PF, Dries DJ, Alazraki N, Albo D Jr. Indium-111-labeled leukocyte scanning for detection of prosthetic vascular graft infection. J Vasc Surg 1985; 2:165173. Go to original source...
    81. Bhat TJ, Tellis VA, Kohlberg WI, Driscoll B, Veith FJ. Management of sepsis involving ePTFE grafts for hemodialysis access. Surgery 1980; 87:445450.
    82. Taylor B, Sigley RD, May KJ. Fate of infected and eroded hemodialysis grafts and autogenous fistulas. Am J Surg 1993; 165:632636. Go to original source... Go to PubMed...
    83. Haug M. Der komplizierter av shunt infolge aerterieller Probleme. Angioarchiv 1991; 22:1517.
    84. Humphries ALJr, Nesbit RRJr, Caruana RJ, Hutchins RS, Heimburger RA, Wray CH. Thirty-six recommendations for vascular access operation: lessons learned from our first thousands operations. Am. Surg 1981; 47:145151.
    85. Schanzer A, Ciaranello AL, Schanzer H. Brachial artery ligation with total graft excision is a safe and effective approach to prosthetic arteriovenous graft infection. J Vasc Surg 2008; 48:655658. Go to original source... Go to PubMed...
    86. Gifford RR. Management of tunnel infections of dialysis PTFE grafts. J Vasc Surg 1985; 2:854858. Go to original source... Go to PubMed...
    87. Calligaro KD, Veith FJ, Valladares JA, McKay J, Schindler N, Dougherty MJ. Prosthetic patch remnants to treat infected arterial grafts. J Vasc Surg 2000; 31:245252. Go to original source... Go to PubMed...
    88. Wu MY, Ko PJ, Hsieh HC, Chu JJ, Lin PJ, Liu YH. Repair of arteriotomy after removal of infected hemodialysis access by venous graft. Chang Gung Med J 2003; 26:911918. Go to original source... Go to PubMed...
    89. Raju S. PTFE grafts for hemodialysis access. Techniques for insertion and management of complications. Ann Surg 1987; 206:666 673. Go to original source... Go to PubMed...
    90. Albers FJ. Clinical considerations in hemodialysis access infection. Adv Ren Replace Ther 1006; 3:208217.
    91. Matsura JH, Johansen KH, Rosenthal D, Clark MD, Clarke KA, Kirby LB. Cryopreserved femoral vein grafts for difficult hemodialysis access. Ann Vasc Surg 2000; 14:5055. Go to original source... Go to PubMed...
    92. Bolton WD, Cull DL, Taylor SM, Carsten CG 3rd, Snyder BA, Sullivan TM et al. The use of cryopreserved femoral vein grafts for hemodialysis access in patients at high risk for infection: a word of caution. J Vasc Surg 2002; 36:464468. Go to original source... Go to PubMed...
    93. Lin PH, Brinkman WT, Terramani TT, Lumsden AB. Management of infected hemodialysis access grafts using cryopreserved human vein allografts. Am J Surg 2002; 184:3136. Go to original source... Go to PubMed...
    94. Madden RL, Lipkowitz GS, Browne BJ, Kurbanov A. Experience with cryopreserved cadaveric femoral vein allografts used for hemodialysis access. Ann Vasc Surg 2004; 18:453458. Go to original source... Go to PubMed...
    95. Madden RL, Lipkowitz GS, Browne BJ, Kurbanov A. A comparison of cryopreserved vein allografts and prosthetic grafts for hemodialysis access. Ann Vasc Surg 2005; 19:686691. Go to original source... Go to PubMed...
    96. Liu Z, Zhu B, Wang X, Jing Y, Wang P, Wang S, Xu H. Clinical studies of hemodialysis access through formaldehyde-fixed arterial allografts. Kidney International 2007; 72:12491254. Go to original source... Go to PubMed...

    Return to the content